Shandong Sito Bio-technology Co., Ltd.
SZSE:300583.SZ
16.34 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,279.783 | 1,312.112 | 1,202.623 | 913.188 | 965.8 | 1,052.277 | 785.566 | 568.246 | 668.167 | 521.011 | 283.588 | 11.032 |
| Cost of Revenue
| 1,011.47 | 1,039.302 | 937.035 | 805.582 | 730.081 | 784.757 | 602.944 | 377.218 | 372.528 | 278.943 | 199.505 | 9.02 |
| Gross Profit
| 268.313 | 272.81 | 265.588 | 107.606 | 235.719 | 267.52 | 182.622 | 191.028 | 295.638 | 242.068 | 84.083 | 2.012 |
| Gross Profit Ratio
| 0.21 | 0.208 | 0.221 | 0.118 | 0.244 | 0.254 | 0.232 | 0.336 | 0.442 | 0.465 | 0.296 | 0.182 |
| Reseach & Development Expenses
| 55.076 | 50.205 | 49.731 | 45.008 | 55.786 | 39.421 | 31.665 | 19.147 | 22.673 | 16.825 | 10.093 | 0 |
| General & Administrative Expenses
| 42.827 | 37.266 | 35.322 | 30.994 | 31.042 | 34.21 | 14.452 | 9.357 | 9.524 | 6.262 | 2.247 | 2.59 |
| Selling & Marketing Expenses
| 5.383 | 14.613 | 13.755 | 15.477 | 12.245 | 9.972 | 11.194 | 5.995 | 5.839 | 4.347 | 2.398 | 0.036 |
| SG&A
| 48.21 | 51.879 | 49.077 | 46.471 | 43.287 | 44.182 | 25.646 | 15.352 | 15.363 | 10.609 | 4.645 | 2.626 |
| Other Expenses
| 132.288 | -1.314 | -1.684 | -6.291 | -2.487 | -0.388 | 0.024 | 1.441 | -0.204 | 7.993 | 1.064 | -0 |
| Operating Expenses
| 235.574 | 189.133 | 168.528 | 187.12 | 149.184 | 121.551 | 89.901 | 60.961 | 58.559 | 38.731 | 19.401 | 2.63 |
| Operating Income
| 32.739 | 49.225 | 55.973 | -186.158 | 67.194 | 149.935 | 103.243 | 114.425 | 218.232 | 195.952 | 54.925 | -1.628 |
| Operating Income Ratio
| 0.026 | 0.038 | 0.047 | -0.204 | 0.07 | 0.142 | 0.131 | 0.201 | 0.327 | 0.376 | 0.194 | -0.148 |
| Total Other Income Expenses Net
| 20.741 | -1.314 | -1.684 | -6.291 | -2.487 | -1.597 | 0.024 | 1.441 | -0.289 | -1.909 | 1.064 | -0 |
| Income Before Tax
| 53.48 | 47.911 | 54.289 | -192.449 | 64.707 | 149.547 | 103.267 | 115.853 | 217.943 | 194.043 | 55.989 | -1.628 |
| Income Before Tax Ratio
| 0.042 | 0.037 | 0.045 | -0.211 | 0.067 | 0.142 | 0.131 | 0.204 | 0.326 | 0.372 | 0.197 | -0.148 |
| Income Tax Expense
| 4.932 | 5.433 | 18.503 | -2.831 | 15.66 | 22.597 | 17.512 | 19.505 | 32.076 | 28.288 | 14.427 | -0.135 |
| Net Income
| 45.604 | 41.967 | 36.205 | -179.807 | 55.309 | 126.849 | 92.002 | 101.177 | 187.045 | 165.754 | 41.562 | -1.493 |
| Net Income Ratio
| 0.036 | 0.032 | 0.03 | -0.197 | 0.057 | 0.121 | 0.117 | 0.178 | 0.28 | 0.318 | 0.147 | -0.135 |
| EPS
| 0.25 | 0.25 | 0.21 | -1.05 | 0.33 | 1.19 | 0.88 | 1.26 | 2.34 | 2.07 | 0.52 | 0 |
| EPS Diluted
| 0.25 | 0.25 | 0.21 | -1.05 | 0.33 | 1.19 | 0.88 | 1.26 | 2.34 | 2.07 | 0.52 | 0 |
| EBITDA
| 264.707 | 190.256 | 217.756 | -17.314 | 179.923 | 222.194 | 175.683 | 161.198 | 254.332 | 220.023 | 64.908 | -0.431 |
| EBITDA Ratio
| 0.207 | 0.195 | 0.196 | 0.072 | 0.185 | 0.224 | 0.22 | 0.306 | 0.404 | 0.422 | 0.243 | -0.039 |